OR7-7: Pasireotide LAR provides superior efficacy over octreotide LAR and lanreotide ATG in patients with inadequately controlled acromegaly: a phase III, multicenter, randomized study (PAOLA)
| Autor: | G. Raverot, Mônica R. Gadelha, Alberto M Pedroncelli, M. Guitelman, V. Pronin, Marcello D. Bronstein, A. Colao, Thierry Brue, M. Aout, Ilan Shimon, Juergen Fleck, M. Coculescu, Maria Fleseriu |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
medicine.medical_specialty
business.industry Endocrinology Diabetes and Metabolism medicine.disease Lanreotide Gastroenterology Octreotide lar Pasireotide law.invention chemistry.chemical_compound Endocrinology chemistry Randomized controlled trial law Internal medicine Acromegaly medicine In patient business |
| Zdroj: | Growth Hormone & IGF Research. 24:S20-S21 |
| ISSN: | 1096-6374 |
| DOI: | 10.1016/s1096-6374(14)50053-6 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect